NasdaqCM - Nasdaq Real Time Price USD
Kazia Therapeutics Limited (KZIA)
3.2400
-0.0600
(-1.82%)
As of 11:42:41 AM EDT. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-22,762.6630
--
--
--
--
Operating Cash Flow
-9,581
-9,581
-15,156
-22,762
-9,111
Investing Cash Flow
--
--
--
-2,365
--
Financing Cash Flow
5,985
5,985
12,972
3,726
28,109
End Cash Position
1,657
1,657
5,241
7,361
27,587
Issuance of Capital Stock
5,580
5,580
12,972
3,726
28,109
Issuance of Debt
776
776
--
--
--
Repayment of Debt
-371
-371
--
--
--
Free Cash Flow
-9,581
-9,581
-15,156
-22,762
-9,111
6/30/2021 - 1/6/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
QNRX Quoin Pharmaceuticals, Ltd.
6.51
+2.68%
SCPX Scorpius Holdings, Inc.
0.0680
-48.48%
CHRO Channel Therapeutics Corporation
1.3650
-0.36%
RLMD Relmada Therapeutics, Inc.
0.6485
-6.00%
GRI GRI Bio, Inc.
1.7300
-5.98%
SLXN Silexion Therapeutics Corp
1.0079
-2.15%
PSTV Plus Therapeutics, Inc.
0.8667
-11.88%
APVO Aptevo Therapeutics Inc.
0.6831
-7.69%
SXTP 60 Degrees Pharmaceuticals, Inc.
3.4100
+13.56%
CMND Clearmind Medicine Inc.
0.9700
-2.50%